Publications by authors named "Ken Ohmine"

Claim this Profile
L
Long lasting complement neutralisation by RAY121, an engineered anti-C1s antibody with C1q displacement function.
Adrian W S Ho, Taku Fukuzawa, Hikaru Koga, Ken Ohmine, Hiroki Kawauchi

EBioMedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trichostatin A Sensitizes Tumor Cells to Apoptosis Induced by Soluble Trimeric TRAIL-Expressing Human Mesenchymal Stromal Cells.
Ryosuke Uchibori, Ken Ohmine, Keiya Ozawa

Cancer Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actual versus ideal donor body weight in planning bone marrow harvest.
Rui Murahashi, Shin-Ichiro Fujiwara, Daisuke Minakata, Masahiro Ashizawa, Chihiro Yamamoto, Ken Ohmine

Transfus Apher Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for influenza virus infection in patients with hematological disease.
Hirotomo Nakashima, Shin-Ichiro Fujiwara, Seina Honda, Ryutaro Tominaga, Daizo Yokoyama, Ken Ohmine

Leuk Lymphoma· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of the tendency for relative bradycardia during induction therapy for acute myeloid leukemia.
Ryutaro Tominaga, Shin-Ichiro Fujiwara, Seina Honda, Daizo Yokoyama, Atsuto Noguchi, Ken Ohmine

Int J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pachydermoperiostosis successfully treated with celecoxib.
Hiroki Yamamoto, Mayumi Komine, Ken Ohmine, Kazue Yoshida, Kazuhiko Nakabayashi

J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCMA-CAR Therapy for Multiple Myeloma in NOG Mice Prevents the Progression of Anemia and Bone Lesions.
Ryosuke Uchibori, Ken Ohmine, Takeshi Teruya, Junichi Mineno, Keiya Ozawa

Hum Gene Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to initial treatment with glucocorticoids in TAFRO syndrome and implications for secondary treatment.
Ryutaro Tominaga, Kento Umino, Seina Honda, Daizo Yokoyama, Atsuto Noguchi, Ken Ohmine

Int J Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Real-World Clinical Factors on an Analysis of the Cost-Effectiveness of "Immediate CAR-T" Versus "Late CAR-T" as Second-Line Treatment for DLBCL Patients.
Chihiro Yamamoto, Seina Honda, Ryutaro Tominaga, Daizo Yokoyama, Shuka Furuki, Ken Ohmine

Transplant Cell Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of daratumumab on the development of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.
Daisuke Minakata, Shin-Ichiro Fujiwara, Seina Honda, Ryutaro Tominaga, Daizo Yokoyama, Ken Ohmine

Bone Marrow Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-Adapted Letermovir Prophylaxis Based on a Scoring System Predicting a Higher Burden of Cytomegalovirus Exposure After Allogeneic Hematopoietic Cell Transplantation.
Shunto Kawamura, Shin-Ichiro Fujiwara, Shun-Ichi Kimura, Junko Takeshita, Hideki Nakasone, Ken Ohmine

Transplant Cell Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-ALL presenting with i-TLP-like indolent clinical course with repeated spontaneous regressions.
Yumiko Toda, Ken Ohmine, Naoki Sano, Naoya Nakamura, Atsushi Kihara

Pathol Res Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the pre-transplant CD4/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation.
Takashi Nagayama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama, Atsuto Noguchi, Ken Ohmine

Leuk Lymphoma· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era.
Yumiko Toda, Masahiro Ashizawa, Rui Murahashi, Hirotomo Nakashima, Takashi Ikeda, Ken Ohmine

Int J Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of CD34 cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation.
Takashi Oyama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama, Atsuto Noguchi, Ken Ohmine

Clin Transplant· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors.
Somsak Prasongtanakij, Sarinthip Preedagasamzin, Bunyada Jittorntrum, Usanarat Anurathapan, Teeraya Puavilai, Ken Ohmine

Eur J Haematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of induction with dasatinib and consolidation with hyper-CVAD plus dasatinib followed by allografting for Ph-positive acute lymphoblastic leukemia in adults.
Iekuni Oh, Kaoru Hatano, Takashi Ikeda, Yumiko Toda, Daisuke Minakata, Ken Ohmine

Leuk Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma.
Chihiro Yamamoto, Daisuke Minakata, Daizo Yokoyama, Shuka Furuki, Atsuto Noguchi, Ken Ohmine

Transplant Cell Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early reversal of the lymphocyte-to-monocyte ratio after allogeneic-hematopoietic stem cell transplantation is associated with reduced relapse and improved prognosis.
Takashi Nagayama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama, Atsuto Noguchi, Ken Ohmine

Clin Transplant· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect.
Kento Umino, Kaoru Morita, Takashi Ikeda, Shin-Ichiro Kawaguchi, Takashi Nagayama, Ken Ohmine

Blood· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies.
Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, Atsuto Noguchi, Shuka Aoe, Ken Ohmine

Br J Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation.
Shin-Ichiro Fujiwara, Rui Murahashi, Hirotomo Nakashima, Sae Matsuoka, Takashi Ikeda, Ken Ohmine

Leuk Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma.
Chihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama, Kaoru Sekiguchi, Yuta Fukui, Ken Ohmine

Blood· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel immunotherapies in multiple myeloma.
Ken Ohmine, Ryosuke Uchibori

Int J Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elimination of plasma soluble antigen in cynomolgus monkeys by combining pH-dependent antigen binding and novel Fc engineering.
Yuji Hori, Ken Ohmine, Hitoshi Katada, Yuki Noguchi, Kazuki Sato

MAbs· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis